-- Eric M Dube, Director, Chief Executive Officer, on April 13, 2026, sold 64,000 shares in Travere Therapeutics (TVTX) for $2,629,975. Following the Form 4 filing with the SEC, Dube has control over a total of 432,886 common shares of the company, with 432,886 shares held directly.
SEC Filing: